Rxivist logo

Exploring repositioning opportunities and side-effects of statins: a Mendelian randomization study of HMG-CoA reductase inhibition with 55 complex traits

By Hon-Cheong So, Carlos Kwan-long Chau, Kai Zhao

Posted 30 Jul 2017
bioRxiv DOI: 10.1101/170241

Statin is one of the most commonly prescribed medications worldwide. Besides reduction of cardiovascular risks, statins have been proposed for the prevention or treatment of other disorders, but results from clinical studies are mixed. There are also controversies concerning the adverse effects caused by statins. In this study we employed a Mendelian randomization (MR) approach across a wide range of complex traits to explore repositioning opportunities and side-effects of statins. MR is analogous to a 'naturalistic' randomized controlled trial (RCT), which is much less susceptible to confounding and reverse causation as compared to observational studies. We employed two genetic instruments (rs12916 and rs17238484) in the HMGCR gene which have been shown to provide reliable estimates of the risk of statins on type 2 diabetes and weight gain. We observed in the single- and joint-SNP analysis that low density lipoprotein cholesterol (LDL-C) reduction from HMG-CoA reductase inhibition results in increased depressive symptoms. This finding appeared to be supported by nominally significant results of raised major depression risk in single-SNP MR analysis of rs17238484, and analyses using LDL-C as the exposure. Several other outcomes also reached nominal significance (p < 0.05) in single- or joint-SNP analyses; for example, we observed causal associations of LDL-C lowering from HMG-CoA reductase inhibition with reduced risks of schizophrenia, anorexia nervosa, Alzheimer disease, Parkinson disease, as well as increased forearm bone mineral density, sleep duration and extreme longevity (highest q-value = 0.289). We also found evidence of casual relationships of LDL-C levels with schizophrenia, anorexia, sleep duration and longevity, following the same association directions as in analyses of HMGCR variants. These findings were at least partially supported by previous clinical studies. We did not observe associations with cognitive test profiles, renal outcomes, autoimmune diseases or cancers. While MR has its limitations and our findings remain to be confirmed in further studies, this work demonstrates the potential of a phenome-wide approach to reveal novel therapeutic indications and unknown drug side-effects.

Download data

  • Downloaded 640 times
  • Download rankings, all-time:
    • Site-wide: 22,522 out of 89,008
    • In genetics: 1,417 out of 4,605
  • Year to date:
    • Site-wide: 48,524 out of 89,008
  • Since beginning of last month:
    • Site-wide: 41,547 out of 89,008

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)